EXICURE, INC. (Nasdaq:XCUR)

Health Care/Life Sciences • Biotechnology

CIK 1698530

Company

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.

Address
2430 North Halsted Street
Chicago, Illinois 60614

Employees
6

Stock Info

Close
$9.95

Day Range
9.70 - 13.40

52 Week Range
1.44 - 36.00

Average volume
123.73K

Short Interest
22.66K (02/14/25)

% of Float Shorted
5.96%

Market Cap
$25.93M

Revenue
N/A

Net Income
-$16.91M

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$2.26

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Chief Financial Officer, Secretary & Director
Seung-Ik Baik

Director
Min Woo Kang

Director
Sang Wook Song

Director
Chang Keun Choi

Director
Ho Jung John

SEC filings

Date	Form	Event
20 Dec, 2024	8-K
17 Dec, 2024	8-K
11 Dec, 2024	8-K
2 Dec, 2024	DEF 14A
29 Nov, 2024	3
29 Nov, 2024	SC 13D
26 Nov, 2024	3
26 Nov, 2024	4
26 Nov, 2024	3
25 Nov, 2024	8-K
22 Nov, 2024	PRE 14A
20 Nov, 2024	8-K
14 Nov, 2024	8-K
14 Nov, 2024	10-Q
30 Sep, 2024	8-K
18 Sep, 2024	8-K
16 Sep, 2024	4
16 Sep, 2024	SC 13D/A
13 Sep, 2024	8-K
26 Aug, 2024	8-K
21 Aug, 2024	4
19 Aug, 2024	8-K
15 Aug, 2024	8-K
13 Aug, 2024	10-Q
13 Aug, 2024	8-K
5 Aug, 2024	SC 13D/A
1 Aug, 2024	8-K
30 Jul, 2024	DEF 14A
19 Jul, 2024	PRE 14A
2 Jul, 2024	SC 13D/A
1 Jul, 2024	8-K
25 Jun, 2024	8-K
17 Jun, 2024	10-Q
17 Jun, 2024	8-K
11 Jun, 2024	DEF 14A
11 Jun, 2024	ARS
6 Jun, 2024	8-K
6 Jun, 2024	10-Q/A
6 Jun, 2024	10-Q/A
6 Jun, 2024	10-K
23 May, 2024	8-K
23 May, 2024	4
16 May, 2024	10-Q/A
16 May, 2024	8-K
16 May, 2024	10-Q
16 May, 2024	10-Q/A
15 May, 2024	NT 10-Q
22 Apr, 2024	8-K
1 Apr, 2024	NT 10-K
6 Mar, 2024	4
4 Mar, 2024	SC 13D/A
4 Mar, 2024	4
5 Feb, 2024	8-K
16 Jan, 2024	8-K
1 Dec, 2023	8-K
1 Dec, 2023	4
28 Nov, 2023	8-K
14 Nov, 2023	NT 10-Q
6 Oct, 2023	8-K
29 Sep, 2023	3
27 Sep, 2023	8-K
13 Sep, 2023	8-K
31 Aug, 2023	3
31 Aug, 2023	3
31 Aug, 2023	3
23 Aug, 2023	8-K	CEO Change
18 Aug, 2023	4
11 Aug, 2023	8-K
11 Aug, 2023	10-Q
9 Aug, 2023	8-K
8 Aug, 2023	SC 13D/A
4 Aug, 2023	8-K
28 Jun, 2023	SC 13D/A
27 Jun, 2023	3
27 Jun, 2023	4
14 Jun, 2023	8-K
6 Jun, 2023	8-K
1 Jun, 2023	8-K
26 May, 2023	8-K
25 May, 2023	4
19 May, 2023	8-K
18 May, 2023	8-K
17 May, 2023	SC 13D/A
15 May, 2023	NT 10-Q
15 May, 2023	3/A
15 May, 2023	3
11 May, 2023	8-K
9 May, 2023	3
9 May, 2023	8-K
5 May, 2023	3
4 May, 2023	8-K
2 May, 2023	8-K	CEO Change
1 May, 2023	SC 13D/A
1 May, 2023	10-K/A
27 Apr, 2023	8-K
13 Apr, 2023	SC 13D/A
27 Mar, 2023	8-K
27 Mar, 2023	10-K
9 Mar, 2023	4
9 Mar, 2023	3
6 Mar, 2023	3
6 Mar, 2023	3
6 Mar, 2023	3
6 Mar, 2023	3
3 Mar, 2023	SC 13D/A
2 Mar, 2023	8-K
24 Feb, 2023	8-K
21 Feb, 2023	8-K
14 Feb, 2023	SC 13G/A
13 Feb, 2023	SC 13D/A
10 Feb, 2023	8-K
9 Feb, 2023	SC 13G/A
23 Jan, 2023	SC 13D/A
20 Jan, 2023	8-K
4 Jan, 2023	4
4 Jan, 2023	3
30 Dec, 2022	8-K
19 Dec, 2022	4
19 Dec, 2022	SC 13D/A
16 Dec, 2022	8-K
14 Dec, 2022	DEFA14A
14 Dec, 2022	8-K
6 Dec, 2022	SC 13G
5 Dec, 2022	SC 13D/A
14 Nov, 2022	8-K
14 Nov, 2022	DEFA14A
14 Nov, 2022	10-Q
10 Nov, 2022	DEF 14A
31 Oct, 2022	8-K
31 Oct, 2022	PRE 14A
31 Oct, 2022	SC 13D/A
27 Sep, 2022	8-K
24 Aug, 2022	8-K
15 Aug, 2022	8-K
15 Aug, 2022	10-Q
11 Aug, 2022	SC 13D/A
20 Jul, 2022	8-K
20 Jul, 2022	424B3
20 Jul, 2022	EFFECT
18 Jul, 2022	CORRESP
18 Jul, 2022	UPLOAD
11 Jul, 2022	S-3
29 Jun, 2022	8-K
15 Jun, 2022	4
15 Jun, 2022	4
15 Jun, 2022	4
15 Jun, 2022	4
13 Jun, 2022	8-K
1 Jun, 2022	SC 13D
31 May, 2022	3
27 May, 2022	8-K
20 May, 2022	4
20 May, 2022	3
19 May, 2022	4
18 May, 2022	4
18 May, 2022	4
16 May, 2022	8-K
16 May, 2022	10-Q
13 May, 2022	8-K
11 May, 2022	SC 13D/A
12 Apr, 2022	DEFA14A
12 Apr, 2022	DEF 14A
1 Apr, 2022	PRE 14A
25 Mar, 2022	S-8
25 Mar, 2022	8-K
25 Mar, 2022	10-K
18 Mar, 2022	8-K
25 Feb, 2022	SC 13D/A
15 Feb, 2022	SC 13G
14 Feb, 2022	SC 13G/A
4 Feb, 2022	8-K	CEO Change
18 Jan, 2022	8-K
5 Jan, 2022	8-K
22 Dec, 2021	4
22 Dec, 2021	SC 13G/A
16 Dec, 2021	424B5
16 Dec, 2021	8-K
10 Dec, 2021	8-K	CEO Change
23 Nov, 2021	4
23 Nov, 2021	4
19 Nov, 2021	8-K
19 Nov, 2021	10-Q
15 Nov, 2021	NT 10-Q
6 Oct, 2021	8-K
8 Sep, 2021	4
20 Aug, 2021	SC 13G
12 Aug, 2021	8-K
12 Aug, 2021	10-Q
5 Aug, 2021	8-K
2 Aug, 2021	8-K
15 Jul, 2021	8-K
15 Jun, 2021	3
4 Jun, 2021	4
4 Jun, 2021	4
4 Jun, 2021	4
4 Jun, 2021	4
4 Jun, 2021	4
4 Jun, 2021	4
4 Jun, 2021	4
3 Jun, 2021	8-K
2 Jun, 2021	8-K
20 May, 2021	4
20 May, 2021	4
20 May, 2021	4
14 May, 2021	4
14 May, 2021	3
13 May, 2021	8-K
12 May, 2021	8-K
12 May, 2021	10-Q
4 May, 2021	4
29 Apr, 2021	4
29 Apr, 2021	4
22 Apr, 2021	DEF 14A
22 Apr, 2021	DEFA14A
20 Apr, 2021	8-K
9 Apr, 2021	8-K
12 Mar, 2021	S-8
11 Mar, 2021	8-K
11 Mar, 2021	10-K
9 Mar, 2021	8-K
8 Mar, 2021	3
8 Mar, 2021	3
8 Mar, 2021	4
8 Mar, 2021	4
3 Mar, 2021	8-K
11 Jan, 2021	8-K
7 Jan, 2021	EFFECT
7 Jan, 2021	8-K
5 Jan, 2021	8-K
5 Jan, 2021	4
5 Jan, 2021	3
5 Jan, 2021	CORRESP
23 Dec, 2020	UPLOAD

Last update:2025-03-06 13:04:39.971253

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.